Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma

Name: Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma
License: Public Domain

Beijing Biotech

ClinicalTrials.gov · Datasets · License: Public Domain

b2 thymoma, thymic carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 429758
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.